ATE178204T1 - Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer - Google Patents

Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer

Info

Publication number
ATE178204T1
ATE178204T1 AT95942772T AT95942772T ATE178204T1 AT E178204 T1 ATE178204 T1 AT E178204T1 AT 95942772 T AT95942772 T AT 95942772T AT 95942772 T AT95942772 T AT 95942772T AT E178204 T1 ATE178204 T1 AT E178204T1
Authority
AT
Austria
Prior art keywords
17beta
administration
intravaginal device
oestradiol precursor
oestradiol
Prior art date
Application number
AT95942772T
Other languages
English (en)
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Application granted granted Critical
Publication of ATE178204T1 publication Critical patent/ATE178204T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT95942772T 1994-12-19 1995-12-19 Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer ATE178204T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05

Publications (1)

Publication Number Publication Date
ATE178204T1 true ATE178204T1 (de) 1999-04-15

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95942772T ATE178204T1 (de) 1994-12-19 1995-12-19 Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer

Country Status (19)

Country Link
US (1) US5855906A (de)
EP (1) EP0799025B1 (de)
JP (1) JPH10510825A (de)
CN (1) CN1138526C (de)
AR (1) AR002010A1 (de)
AT (1) ATE178204T1 (de)
AU (1) AU692659B2 (de)
CA (1) CA2207622C (de)
DE (1) DE69508791T2 (de)
DK (1) DK0799025T3 (de)
ES (1) ES2133841T3 (de)
FI (1) FI119414B (de)
GR (1) GR3030614T3 (de)
IL (1) IL116433A (de)
NO (1) NO316707B1 (de)
NZ (1) NZ298490A (de)
PE (1) PE62796A1 (de)
TR (1) TR199501599A2 (de)
WO (1) WO1996019196A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
AU741482B2 (en) * 1997-05-07 2001-11-29 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) * 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
EP1494646B2 (de) * 2002-03-27 2017-10-04 Warner Chilcott (Ireland) Limited Intravaginale matrix-verabreichungsvorrichtung
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
JP4898431B2 (ja) * 2003-04-29 2012-03-14 ザ ジェネラル ホスピタル コーポレイション 複数薬物の持続放出のための方法およびデバイス
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
EP1853221A2 (de) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Vorrichtungen zur abgabe von mitteln in einen vaginaltrakt
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
JP5137841B2 (ja) 2005-10-13 2013-02-06 シンセス ゲーエムベーハー 薬物含浸容器
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
ES2696999T3 (es) * 2007-06-26 2019-01-21 Allergan Pharmaceuticals Int Ltd Dispositivos de administración intravaginal de medicamentos para la administración de macromoléculas y medicamentos solubles en agua
US9586035B2 (en) * 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
EP2437684B1 (de) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Wirkstofffreisetzung im vorderen augensegment
AU2010265863C1 (en) 2009-06-26 2012-11-01 Taris Biomedical Llc Implantable drug delivery devices and methods of making the same
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
CA2823783C (en) 2011-01-10 2023-03-21 Taris Biomedical, Inc. Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
RU2598057C2 (ru) 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
CA2848397C (en) 2011-09-14 2022-04-26 Forsight Vision5, Inc. Ocular insert apparatus and methods
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
WO2014066775A1 (en) 2012-10-26 2014-05-01 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
HUE072250T2 (hu) 2013-03-15 2025-11-28 Taris Biomedical Llc Gyógyszeradagoló eszközök gyógyszeráteresztõ résszel
BR112015032045B1 (pt) 2013-06-21 2020-06-09 Depuy Synthes Products Inc corpo flexível, método para formar um filme multicamadas para uso em combinação com um dispositivo médico implantável, sistema de armazenamento de filme e sistema para tratamento ortopédico
ES2956840T3 (es) 2013-08-19 2023-12-29 Taris Biomedical Llc Dispositivos de administración de fármacos de múltiples unidades
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN112494195A (zh) * 2014-04-01 2021-03-16 保利医学公司 避孕装置及相关装置
EP3283004A4 (de) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Augeneinsatzzusammensetzung aus einem semikristallinen oder kristallinen pharmazeutischen wirkstoff
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
CN114573654B (zh) * 2020-12-01 2025-09-12 北京奇明达企业管理有限公司 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
WO1996019196A1 (en) 1996-06-27
US5855906A (en) 1999-01-05
FI972579A0 (fi) 1997-06-17
IL116433A (en) 2002-02-10
CN1170353A (zh) 1998-01-14
EP0799025B1 (de) 1999-03-31
FI119414B (fi) 2008-11-14
GR3030614T3 (en) 1999-10-29
EP0799025A1 (de) 1997-10-08
NO972798L (no) 1997-08-19
AU692659B2 (en) 1998-06-11
DK0799025T3 (da) 1999-10-18
NO972798D0 (no) 1997-06-17
ES2133841T3 (es) 1999-09-16
DE69508791D1 (de) 1999-05-06
CA2207622A1 (en) 1996-06-27
NZ298490A (en) 1999-11-29
PE62796A1 (es) 1996-12-28
NO316707B1 (no) 2004-04-13
CA2207622C (en) 2006-10-17
JPH10510825A (ja) 1998-10-20
FI972579L (fi) 1997-06-17
CN1138526C (zh) 2004-02-18
TR199501599A2 (tr) 1996-07-21
DE69508791T2 (de) 1999-12-02
AU4399196A (en) 1996-07-10
IL116433A0 (en) 1996-03-31
AR002010A1 (es) 1998-01-07

Similar Documents

Publication Publication Date Title
DE69508791D1 (de) Intravaginale vorrichtung zur verabreichung von 17beta-oestradiol vorläufer
DE69522505D1 (de) Saugvorrichtung zur Blutentnahme
DE69308301D1 (de) Vorrichtung zur halterung von kleiderbügel
DE69911125D1 (de) Vorrichtung zur Verabreichung von Narkosemitteln
DE69530355D1 (de) Vorrichtung zur medizinischen Intervention
DE69535297D1 (de) Zubereitung multivesikulärer liposomen zur gesteuerten freisetzung von wirkstoffen
DE69513672D1 (de) Verbesserte vorrichtung zur iontophoretischen verabreichung von medikamenten
DE69528303D1 (de) Vorrichtung zur thermischen Behandlung
DE69926686D1 (de) Vorrichtung zur Verabreichung von hochkonzentrierten NO Pulsen
DE69628344D1 (de) Vorrichtung zur Verabreichung einer Substanz
DE69333485D1 (de) Vorrichtung zur ausserkörperlichen blutbehandlung
DE69730882D1 (de) Vorrichtung zur Spritzenanfertigung
DE3751710D1 (de) Arthroscopische chirurgische Vorrichtung
IS4758A (is) Efnasambönd sem örva seyti vaxtarhormóna
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
DE59301231D1 (de) Vorrichtung zur Verriegelung
DE69309763D1 (de) Vorrichtung zur Herstellung von Rohren
DE69734082D1 (de) Vorrichtung zur Synchronisierung
FI904755A7 (fi) Yhdistetty kirurginen neulasutuuralaite ja menetelmä sen valmistamiseksi
DE69711311D1 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69506019D1 (de) Vorrichtung zur Behandlung von Schmerz
DE59406023D1 (de) Vorrichtung zur Verriegelung
DE59509949D1 (de) Vorrichtung zur strahlteilung
DE69831292D1 (de) Vorrichtung zur bildunterstützten thorax-therapie
DE69631957D1 (de) Chirurgische Vorrichtung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee